menu

Quintiles Library

Show Filters
Article
Integrated Channel Management offers an approach to combine e-solutions and traditional channels into a customized and cost-effective and optimized communications mix. Read more on what Peter Dussias has to say on this approach. Authors: Peter Dussias, Sr. Director Integrated Channel Management, North America
Read More
Brochure
The emerging markets of Asia Pacific offer tremendous potential for clinical research, but differences in patient populations, infrastructure and the number of available investigators make completing studies on time and within internationally recognized quality standards a complex undertaking. Quintiles offers the experience, expertise and strategy that can accelerate...
Read more
Fact Sheet
The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) are increasingly proactive in ensuring that the benefit-risk balance of a medicine is positive throughout the entire life cycle of a medicine for all patients in the target population. Both the EMA and the FDA are making transparency a priority; proactively seeking the viewpoints of...
Read More
Article
In nonexperimental research, missing data pose an increased threat to validity compared with well-conducted randomized clinical trials. However, nonexperimental real-world studies can compensate for these limitations by providing a more accurate picture of how well medical interventions work in real-life settings and for diverse patient populations. Recognizing that some...
Read More
Brochure
Maximize your commercial success by knowing how to navigate the UK healthcare system. Starting with identification of the key stakeholders involved in drug adoption, getting access to them to engage them in a dialog about your new therapy, and also get their views on potential patient-centric programs that could help achieve better patient outcomes in their communities....
Read More
Press Release
SEOUL – January 23, 2015 – Quintiles today announced the launch of a handbook to guide physicians in the conduct of investigator initiated clinical trials. Top clinical researchers from academia and industry across Asia-Pacific joined Quintiles’ experts in contributing to and editing the handbook, which Quintiles sponsored as part of its ongoing efforts to enhance...
Read More
White Paper
Quintiles has developed a two-part global investigation in more than 100 countries to confirm “what works where” for patient recruitment and retention tools and techniques. Authors: Chris Frega, Senior Director, Integrated Site Services & Stacy Whaley, Associate Director, Patient & Site Services
Explore More
Press Release
RESEARCH TRIANGLE PARK, N.C. – January 19, 2015 – Quintiles Transnational Holdings Inc. (NYSE: Q) will release its fourth-quarter 2014 financial results Thursday, February 12, 2015 prior to its quarterly earnings call at 8:00 a.m. EST. The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – January 15, 2015 – Expression Analysis (EA), a Quintiles company, today announced the winners of a grant program that provides scientists with leading-edge products and services to advance genomics research. In this sixth year of the program, EA and co-sponsor, Illumina, awarded two fully funded research grants to investigate genomic data...
Read More
White Paper
Autism spectrum disorder (ASD) – a group of conditions characterized by deficits in social interactions and communication skills, as well as the presence of stereotypic and repetitive behaviors – is estimated to affect 1% of the global population.[i] A recent review of published data concluded that the median of prevalence estimates of autism spectrum disorder worldwide...
Explore here
White Paper
Biomarkers hold promise in the diagnosis, prognosis and therapeutic stratification of hematopoietic malignancies. These heterogeneous diseases – including multiple myeloma, lymphomas and leukemias – are frequently characterized cytogenetically with diagnoses supported by genetic, immunohistochemical and flow cytometric analyses. Biomarkers offer the hope of early...
Explore here
White Paper
Other than skin cancer, prostate cancer is the most common cancer in American men. The American Cancer Society estimates that in 2013, about 238,590 new cases of prostate cancer will be diagnosed, and around 29,720 men will die of prostate cancer; some one in six men will be diagnosed with prostate cancer during his lifetime. Due to its widespread incidence and unmet...
Explore here
White Paper
The current biopharma drug development paradigm, including an organizational structure centered around project teams, is not well-constituted to embody design best practices even though design of clinical trials is at the heart of the drug development endeavor. Teams tend to be formed on the basis of technical or therapeutic expertise, not on the basis of well-honed...
Explore here
White Paper
The biopharmaceutical industry is currently facing a number of macro-environmental factors, which underscore its need to think of itself not as a developer of singular products, but as a critical part of an interoperable system. This fundamental shift must include a strategic approach for engaging with an increasingly informed and connected patient population. The amount...
Explore here
White Paper
Organizations and entrepreneurs have tapped into the power of crowds for many generations. With the pervasiveness of social platforms have come new, simpler, and more economical methods to draw upon the capabilities of a truly global crowd. In this paper we present three case studies in which crowdsourcing was used in the healthcare industry. From these scenarios we...
Explore here
Media Coverage
As featured in the December 2014 issue of Pharmaceutical Field, John Pinching talks to Quintiles' Tanya Byron about how E-detailing is changing perceptions and providing an effective sales platform for engaging with customers.
Read More
Fact Sheet
Quintiles’ Diabetes Center of Excellence couples our therapeutic expertise with a proven ability to recruit patients across the globe to help you realize the full potential of your drug development investment.
Read more
Fact Sheet
For one of the most mature markets in the world, Japan continues to offer huge opportunities for growth. It is the largest pharmaceutical market in the Asia Pacific region and second only to North America worldwide. With government healthcare reforms spurring innovation, Japan equals the promise of emerging countries without the risk. Quintiles’ integrated teams, backed...
Read more
Fact Sheet
Pharmaceutical companies are crossing borders around the globe, leading many to seek the best markets for expansion. Japan is often at the top of that list. As the second largest pharma market in the world, Japan offers advantages from universal healthcare coverage to extended patent cycles to government support of innovation. Entering the Japanese market, however,...
Read more
White Paper
With payers playing an increasingly critical role in physician prescribing practices, regulatory approval is no longer the end game of drug development. Market access is now the goal line for product success, requiring that payer priorities be integrated at every stage of product strategy in order demonstrate evidence of value. How to navigate the new world of drug...
Explore here